Close

BioCryst Pharma (BCRX) Will Make Late-Breaker Presentation on Galidesivir Study in ZIKV-Infected Monkeys

Go back to BioCryst Pharma (BCRX) Will Make Late-Breaker Presentation on Galidesivir Study in ZIKV-Infected Monkeys